[1] 徐惠绵, 王鑫. 我国胃癌诊治临床研究现状与展望[J]. 中华胃肠外科杂志, 2020, 23(2):109-114. [2] 曹毛毛, 李贺, 孙殿钦, 等. 2000-2019年中国胃癌流行病学趋势分析[J]. 中华消化外科杂志, 2021, 20(1):102-109. [3] 何小霞, 李宝钏. 腹腔镜与开腹根治术对进展期胃癌患者机体炎症反应、免疫功能及疼痛因子的影响[J]. 中国现代医学杂志, 2021, 31(6):23-26. [4] YANG X X, SONG X, ZHANG L, et al. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer:a systematic review and meta-analysis[J]. Medicine (Baltimore), 2020, 99(10):e19362. [5] SHEN L L, TANG Y H, QIU W W, et al. 140P Preoperative and postoperative C-reactive protein levels predict recurrence and chemotherapy benefit in gastric cancer[J]. Ann Oncol, 2020, 31:S1296. [6] BLASCO M T, GOMIS R R. PD-L1 controls cancer pyroptosis[J]. Nat Cell Biol, 2020, 22(10):1157-1159. [7] LIN Y S, ZHENG Y, WANG H L, et al. Global patterns and trends in gastric cancer incidence rates (1988-2012) and predictions to 2030[J]. Gastroenterology, 2021, 161(1):116-127. [8] ABDUL PARI A A, SINGHAL M, HÜBERS C, et al. Tumor cell-derived angiopoietin-2 promotes metastasis in melanoma[J]. Cancer Res, 2020, 80(12):2586-2598. [9] PEDERSEN C K, BABU A S. Understanding the lymphatics:review of the N category in the updated TNM staging of cancers of the digestive system[J]. AJR Am J Roentgenol, 2020, 215(1):58-68. [10] 黄丹, 朱雄增, 盛伟琪. 2019版《WHO消化系统肿瘤分类》胃肠上皮性肿瘤部分解读[J]. 中华病理学杂志, 2020, 49(3):209-213. [11] 寸红丽, 李华秀, 张大福, 等. 双能CT影像组学在诊断不同分化程度胃癌中的应用[J]. 中国医学影像学杂志, 2020, 28(9):669-672, 687. [12] 董海军, 沈建伟, 沈睿炜, 等. TGF-β1和miR-146a在幽门螺杆菌感染患者胃黏膜组织中的表达及意义[J]. 中华医院感染学杂志, 2021, 31(9):1292-1295. [13] 中国抗癌协会胃癌专业委员会.胃癌诊治难点中国专家共识(2020版)[J]. 中国实用外科杂志, 2020, 40(8):869-904. [14] KONO Y, KANZAKI H, IWAMURO M, et al. Reality of gastric cancer in young patients:the importance and difficulty of the early diagnosis, prevention and treatment[J]. Acta Med Okayama, 2020, 74(6):461-466. [15] 杜奕奇, 李兆申. 我国消化道早癌筛查的挑战和展望[J]. 第二军医大学学报, 2020, 41(1):1-5. [16] 王霄腾, 冀子中, 韩丰, 等. 新型胃癌筛查评分系统与血清学新ABC法在胃癌及癌前病变筛查中的比较研究[J]. 中华内科杂志, 2021, 60(3):227-232. [17] 戚宇锋, 徐克群, 朱颖蔚, 等. 多种血清细胞因子联合检测对胃腺癌的诊断价值[J]. 中国肿瘤生物治疗杂志, 2020, 27(4):410-415. [18] WAKAHARA T, KANEMITSU K, ASARI S, et al. The combined use of drainage amylase concentration and serum C-reactive protein as predictors of pancreas-related complications after elective gastrectomy[J]. Oncology, 2020, 98(2):111-116. [19] HAGI T, KUROKAWA Y, KAWABATA R, et al. Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer[J]. Br J Cancer, 2020, 123(6):965-972. [20] PEREIRA M A, FERNANDO KODAMA P RAMOS M, RIBEIRO E RIBEIRO R, et al. Immunohistochemical scores for programmed death ligand-1(PD-L1) expression and prognostic in patients with gastric cancer[J]. J Am Coll Surg, 2020, 231(4):e208. [21] 陈小华, 梁盼, 高剑波. 胃癌血管生成的影像学研究进展[J]. 中华放射学杂志, 2021, 55(3):329-332. [22] YOODEE S, PEERAPEN P, PLUMWORASAWAT S, et al. ARID1A knockdown in human endothelial cells directly induces angiogenesis by regulating angiopoietin-2 secretion and endothelial cell activity[J]. Int J Biol Macromol, 2021, 180:1-13. [23] KALLIO P, JOKINEN E, HÖGSTRÖM J, et al. Blocking angiopoietin-2 promotes vascular damage and growth inhibition in mouse tumors treated with small doses of radiation[J]. Cancer Res, 2020, 80(12):2639-2650. [24] LIU T, ZHANG Q S, SONG C H, et al. C-reactive protein trajectories and the risk of all cancer types:a prospective cohort study[J]. Int J Cancer, 2022, 151(2):297-307. [25] PULIANI G, SESTI F, ANASTASI E, et al. Angiogenic factors as prognostic markers in neuroendocrine neoplasms[J]. Endocrine, 2022, 76(1):208-217. [26] PARK Y, KOH J, NA H Y, et al. PD-L1 testing in gastric cancer by the combined positive score of the 22C3 PharmDx and SP263 assay with clinically relevant cut-offs[J]. Cancer Res Treat, 2020, 52(3):661-670. |